Adenocarcinoma of the Pancreas Active Not Recruiting Phase 1 Trials for Ceritinib (DB09063)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02227940Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic CancerTreatment